ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for t

Publication Year:
1994

No metrics available.

Repository URL:
https://digitalcommons.portlandlibrary.com/news_pph/14372
Author(s):
Gormley, John
Tags:
Biotechnology industries; ImmuCell Corp -- Portland
article description
ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for the creation and marketing of biotechnology products. The company currently makes $1 million annually from sales of First Defense, a veterinary product that prevents newborn cows from a lethal parasitic illness called scours. IT is working on a drug to protect people against a common form of severe diarrhea known as traveler's disease. Details.